| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Revenue | $425.6M | — |
| Cost of Revenue | $223.0M | — |
| Gross Profit | $202.6M | — |
| R&D Expense | $79.7M | — |
| SG&A Expense | $69.9M | — |
| Operating Income | -$118.0M | — |
| Interest Expense | $33.7M | — |
| Pre-tax Income | -$220.0M | — |
| Income Tax | -$30.1M | — |
| Net Income | -$165.8M | — |
| EPS (Basic) | -$0.68 | — |
| EPS (Diluted) | -$0.68 | — |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.5M | -20.2% |
| Accounts Receivable | $155.3M | +37.9% |
| Current Assets | $356.1M | +7.0% |
| Total Assets | $5.41B | +40.8% |
| Current Liabilities | $440.4M | +139.4% |
| Long-term Debt | $952.7M | +87.8% |
| Total Liabilities | $1.92B | +41.2% |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.2M | — |
| Capital Expenditures | $31.8M | — |
| Investing Cash Flow | -$808.5M | — |
| Financing Cash Flow | $710.7M | — |
| Free Cash Flow | $19.4M | — |
| Stockholders' Equity |
| $3.19B |
| +52.8% |